Nu Skin Enterprises, Inc. (NYSE:NUS) CFO Mark H. Lawrence sold 500 shares of the business’s stock in a transaction dated Thursday, May 6th. The stock was sold at an average price of $55.00, for a total value of $27,500.00. Following the sale, the chief financial officer now owns 47,844 shares in the company, valued at $2,631,420. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink.
NYSE NUS traded up $0.75 on Friday, reaching $58.95. The company had a trading volume of 666,612 shares, compared to its average volume of 527,550. The stock has a market capitalization of $3.00 billion, a P/E ratio of 19.60, a P/E/G ratio of 2.03 and a beta of 1.37. The company has a quick ratio of 1.08, a current ratio of 1.66 and a debt-to-equity ratio of 0.38. The company’s fifty day moving average is $53.10 and its 200 day moving average is $53.33. Nu Skin Enterprises, Inc. has a 52-week low of $31.30 and a 52-week high of $63.85.
Nu Skin Enterprises (NYSE:NUS) last posted its quarterly earnings results on Wednesday, May 5th. The company reported $0.91 earnings per share for the quarter, topping the consensus estimate of $0.72 by $0.19. Nu Skin Enterprises had a return on equity of 19.18% and a net margin of 6.54%. On average, research analysts expect that Nu Skin Enterprises, Inc. will post 3.4 EPS for the current year.
The company also recently declared a quarterly dividend, which will be paid on Wednesday, June 9th. Stockholders of record on Friday, May 28th will be paid a dividend of $0.38 per share. The ex-dividend date is Thursday, May 27th. This represents a $1.52 annualized dividend and a dividend yield of 2.58%. Nu Skin Enterprises’s payout ratio is 49.03%.
Several brokerages recently commented on NUS. Jefferies Financial Group upped their target price on Nu Skin Enterprises from $60.00 to $66.00 and gave the company a “buy” rating in a report on Tuesday, February 2nd. Deutsche Bank Aktiengesellschaft boosted their price target on Nu Skin Enterprises from $57.00 to $64.00 and gave the company a “hold” rating in a research note on Thursday. Finally, DA Davidson lowered Nu Skin Enterprises from a “buy” rating to a “neutral” rating and lowered their target price for the stock from $71.00 to $58.00 in a research report on Friday, February 12th. Six research analysts have rated the stock with a hold rating and two have given a buy rating to the company. Nu Skin Enterprises presently has an average rating of “Hold” and an average price target of $57.00.
Hedge funds have recently bought and sold shares of the company. Norges Bank purchased a new stake in Nu Skin Enterprises during the 4th quarter worth about $46,393,000. SummerHaven Investment Management LLC purchased a new stake in Nu Skin Enterprises during the 4th quarter worth about $511,000. Renaissance Technologies LLC lifted its holdings in Nu Skin Enterprises by 15.6% during the 4th quarter. Renaissance Technologies LLC now owns 2,723,596 shares of the company’s stock worth $148,790,000 after purchasing an additional 367,096 shares in the last quarter. LSV Asset Management lifted its holdings in Nu Skin Enterprises by 103.0% during the 1st quarter. LSV Asset Management now owns 611,573 shares of the company’s stock worth $32,346,000 after purchasing an additional 310,273 shares in the last quarter. Finally, Healthcare of Ontario Pension Plan Trust Fund purchased a new stake in Nu Skin Enterprises during the 4th quarter worth about $13,365,000. Institutional investors own 73.75% of the company’s stock.
About Nu Skin Enterprises
Nu Skin Enterprises, Inc develops and distributes personal care and wellness products worldwide. It provides skin care systems, including ageLOC Me customized skin care and ageLOC Spa systems, and ageLOC LumiSpa skin treatment and cleansing devices; and Epoch products comprising botanical ingredients derived from renewable sources, as well as a range of other cosmetic and personal care products.
Read More: Do Tariffs Work?
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Featured Article: Depreciation
Despite their disagreements (real or imagined) on almost everything, Democrats and Republicans alike love infrastructure projects. These are easy wins for Congressional leaders seeking re-election. And they typically spur job creation, which contributes to economic growth.
With that in mind, it’s ironic that, in the last four years, the United States Congress did not pass an infrastructure bill.
Nevertheless, even with (and maybe because of) the gridlock that looks to be in the country’s future, the infrastructure looks to be on the front burner again. The economic recovery is still far from complete. Unfortunately, neither are America’s roads, energy grid, telecommunications systems, and the like. That means that it would seem like a good policy for a Biden administration to look at an infrastructure bill.
Biden will be under pressure to endorse the $1.5 trillion infrastructure package that the Democrat-controlled House of Representatives passed in July. But the package may need to be tweaked a bit since it currently includes climate change initiatives that have kept the bill from advancing through the Senate.
However, it appears that the economy will need some significant juice after whatever this winter brings in terms of the virus. And if calmer heads prevail (we can always hope), there may be a major infrastructure bill to stimulate job creation. And we’ve identified seven stocks that should bear watching if this comes to pass.